D. Moody

发表

D. Moody, 2006 .

Drug and alcohol involvement in railroad accidents.

D. Crouch, D. Rollins, D. Moody, 1991, Journal of forensic sciences.

Buprenorphine Duration of Action: Mu-opioid Receptor Availability and Pharmacokinetic and Behavioral Indices

R. Koeppe, M. Greenwald, J. Zubieta, 2007, Biological Psychiatry.

Peroxisome development in the regenerating pars recta (P3 segment) of proximal tubules of the rat kidney.

J. Reddy, M. Rao, S. Qureshi, 1976, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

Comparative Toxicology of Tetrachlorobiphenyls in Mink and Rats I. Changes in Hepatic Enzyme Activity and Smooth Endoplasmic Reticulum Volume

B. Hammock, W. Helferich, L. Lowenstine, 1987 .

Pharmacokinetic Interactions between Buprenorphine/Naloxone and Raltegravir in Subjects Receiving Chronic Buprenorphine/Naloxone Treatment

G. Friedland, T. Parsons, D. Moody, 2013, The American journal of drug and alcohol abuse.

Metabolic and toxicological considerations of the opioid replacement therapy and analgesic drugs: methadone and buprenorphine

D. Moody, 2013, Expert opinion on drug metabolism & toxicology.

Tipranavir/Ritonavir Induction of Buprenorphine Glucuronide Metabolism in HIV-Negative Subjects Chronically Receiving Buprenorphine/Naloxone

R. D. Bruce, G. Friedland, D. Moody, 2011, The American journal of drug and alcohol abuse.

Pharmacokinetics of buprenorphine following intravenous and oral transmucosal administration in dogs.

L. Maxwell, R. Galinsky, D. Moody, 2008, Veterinary therapeutics : research in applied veterinary medicine.

Pharmacokinetics of Buprenorphine: A Comparison of Sublingual Tablet Versus Liquid after Chronic Dosing

W. Ling, A. Huber, C. N. Chiang, 2007, Journal of addiction medicine.

The In Vivo Glucuronidation of Buprenorphine and Norbuprenorphine Determined by Liquid Chromatography-Electrospray Ionization-Tandem Mass Spectrometry

E. McCance-Katz, D. Moody, Wei Huang, 2006, Therapeutic drug monitoring.

Pharmacokinetic interactions between buprenorphine and antiretroviral medications.

R. D. Bruce, E. Kharasch, E. McCance-Katz, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

NOVEL METABOLITES OF BUPRENORPHINE DETECTED IN HUMAN LIVER MICROSOMES AND HUMAN URINE

E. McCance-Katz, D. Moody, Yan Chang, 2006, Drug Metabolism and Disposition.

Interactions between buprenorphine and antiretrovirals. I. The nonnucleoside reverse-transcriptase inhibitors efavirenz and delavirdine.

P. Jatlow, G. Friedland, Patrick F. Smith, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Interactions between buprenorphine and antiretrovirals: nucleos(t)ide reverse transcriptase inhibitors (NRTI) didanosine, lamivudine, and tenofovir.

E. McCance-Katz, G. Morse, D. Moody, 2010, The American journal on addictions.

Morphometric analysis of the ultrastructural changes in rat liver induced by the peroxisome proliferator SaH 42-348

J. Reddy, D. Moody, J. Reddy, 1976, The Journal of cell biology.

The cardiovascular and subjective effects of methamphetamine combined with γ-vinyl-γ-aminobutyric acid (GVG) in non-treatment seeking methamphetamine-dependent volunteers

S. Shoptaw, E. London, T. Newton, 2009, Pharmacology, Biochemistry and Behavior.

In vitro inhibition of mouse and rat glutathione S-transferases by di(2-ethylhexyl) phthalate, mono(2-ethylhexyl) phthalate, 2-ethylhexanol, 2-ethylhexanoic acid and clofibric acid.

M. Y. Law, D. Moody, 1991, Toxicology in vitro : an international journal published in association with BIBRA.

Fate of systemically administered cocaine in nonhuman primates treated with the dAd5GNE anticocaine vaccine.

G. Koob, R. Crystal, S. Evans, 2014, Human gene therapy. Clinical development.

Sodium cholate extraction of rat liver nuclear xenobiotic-metabolizing enzymes.

D. Geller, B. Hammock, D. Loury, 1988, Biochemical pharmacology.

Determination of nalmefene by high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry.

D. Andrenyak, D. Moody, Wenfang B Fang, 2005, Journal of analytical toxicology.

An enantiomer-selective liquid chromatography-tandem mass spectrometry method for methadone and EDDP validated for use in human plasma, urine, and liver microsomes.

M. Greenwald, D. Moody, Mahmoud S. Ahmed, 2008, Journal of analytical toxicology.

Determination of l-α-acetylmethadol (LAAM), norLAAM, and dinorLAAM in Clinical and In Vitro Samples Using Liquid Chromatography with Electrospray Ionization and Tandem Mass Spectrometry

M. Slawson, D. Moody, Wei Huang, 2003 .

A liquid chromatographic-electrospray-tandem mass spectrometric method for quantitation of quetiapine in human plasma and liver microsomes: application to study in vitro metabolism.

R. Foltz, D. Moody, Yan Chang, 2004, Journal of analytical toxicology.

Hepatic effects of some [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio] acetic acid (WY-14,643) analogs in the mouse.

J. Reddy, D. Azarnoff, D. Moody, 1977, Archives internationales de pharmacodynamie et de therapie.

Rifampin, but not rifabutin, may produce opiate withdrawal in buprenorphine-maintained patients.

G. Friedland, E. McCance-Katz, D. Moody, 2011, Drug and alcohol dependence.

Quantitative analysis of naltrexone and 6beta-naltrexol in human, rat, and rabbit plasma by liquid chromatography-electrospray ionization tandem mass spectrometry with application to the pharmacokinetics of Depotrex in rabbits.

Meng Chen, S. Comer, R. Foltz, 2007, Journal of analytical toxicology.

Determination of ∆-9-Tetrahydrocannabinol (THC), 11-hydroxy-THC, 11-nor-9-carboxy-THC and Cannabidiol in Human Plasma using Gas Chromatography-Tandem Mass Spectrometry.

M. Haney, M. Slawson, D. Andrenyak, 2017, Journal of analytical toxicology.

Immunohistochemical evidence for alterations in specific forms of rat hepatic microsomal cytochrome P-450 during acute carbon tetrachloride intoxication.

E. Smuckler, D. Moody, L. Taylor, 1986, Drug metabolism and disposition: the biological fate of chemicals.

Drug interactions with benzodiazepines

D. Moody, 1984 .

Ankyrin repeat and SOCS box protein 15 regulates protein synthesis in skeletal muscle.

T. McDaneld, D. Moody, K. Hannon, 2006, American journal of physiology. Regulatory, integrative and comparative physiology.

Correlations of the induction of microsomal epoxide hydrolase activity with phase II drug conjugating enzyme activities in rat liver.

M. Slawson, D. Moody, M. R. Franklin, 1996, Toxicology letters.

Variables in human liver microsome preparation: impact on the kinetics of l-alpha-acetylmethadol (LAAM) n-demethylation and dextromethorphan O-demethylation.

D. Moody, A. C. Nelson, W. Huang, 2001, Drug metabolism and disposition: the biological fate of chemicals.

Effects of environmentally encountered epoxides on mouse liver epoxide-metabolizing enzymes.

B. Hammock, D. Moody, M. Ashour, 1991, Biochemical pharmacology.

The effect of tridiphane (2-(3,5-dichlorophenyl)-2-(2,2,2-trichloroethyl)oxirane) on hepatic epoxide-metabolizing enzymes: indications of peroxisome proliferation.

B. Hammock, D. Moody, 1987, Toxicology and applied pharmacology.

Apparent induction of microsomal carboxylesterase activities in tissues of clofibrate-fed mice and rats.

B. Hammock, D. Moody, M. Ashour, 1987, Toxicology and applied pharmacology.

Immunochemical determination of microsomal epoxide hydrolase (preneoplastic antigen) in extrahepatic tissue.

B. Hammock, D. Loury, D. Moody, 1987, Biochemical pharmacology.

Epoxide hydrolysis in the cytosol of rat liver, kidney, and testis. Measurement in the presence of glutathione and the effect of dietary clofibrate.

B. Hammock, D. Moody, M. Silva, 1986, Biochemical pharmacology.

Hepatocellular carcinomas in acatalasemic mice treated with nafenopin, a hypolipidemic peroxisome proliferator.

M. Rao, D. Moody, J. Reddy, 1976, Cancer research.

Mitogenic effect in mouse liver induced by a hypolipidemic drug, nafenopin

M. Rao, D. Moody, J. Reddy, 1977, Virchows Archiv. B, Cell pathology.

1-methyl-4piperidyl-bis (P-chlorophenoxy) acetate: a new hypolipidemic peroxisome proliferator.

D. Azarnoff, D. Moody, T. P. Krishnakantha, 1975, Research communications in chemical pathology and pharmacology.

Increase in hepatic carnitine acetyltransferase activity associated with peroxisomal (microbody) proliferation induced by the hypolipidemic drugs clofibrate, nafenopin, and methyl clofenapate.

D. Moody, J. Reddy, 1974, Research communications in chemical pathology and pharmacology.

Hepatic Catalase Is Not Essential for the Hypolipidemic Action of Peroxisome Proliferators 1

M. Rao, D. Azarnoff, D. Moody, 1977, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Serum triglyceride and cholesterol contents in male rats receiving diets containing plasticizers and analogues of the ester 2-ethylhexanol.

D. Moody, J. Reddy, 1982, Toxicology letters.

The hepatic effects of hypolipidemic drugs (clofibrate, nafenopin, tibric acid, and Wy-14,643) on hepatic peroxisomes and peroxisome-associated enzymes.

D. Moody, J. Reddy, 1978, The American journal of pathology.

Di-(2-ethylhexyl)phthalate: an industrial plasticizer induces hypolipidemia and enhances hepatic catalase and carnitine acetyltransferase activities in rat and mice.

M. Rao, D. Azarnoff, D. Moody, 1976, Life sciences.

Alterations of specific forms of cytochrome P-450 in rat liver during acute carbon tetrachloride intoxication.

E. Smuckler, C. Woo, D. Moody, 1981, Toxicology and applied pharmacology.

Selective induction of rat liver phase II enzymes by N-heterocycle analogues of phenanthrene: a response exhibiting high correlation between UDP-glucuronosyltransferase and microsomal epoxide hydrolase activities.

M. Slawson, D. Moody, M. Franklin, 1993, Xenobiotica; the fate of foreign compounds in biological systems.

Effect of phenobarbital treatment on carbon tetrachloride-mediated cytochrome P-450 loss and diene conjugate formation.

D. Moody, 1992, Toxicology letters.

The effects of dicofol on induction of hepatic microsomal metabolism in rats

B. Hammock, D. Moody, L. Shull, 1987 .

Effect of medroxyprogesterone acetate on hepatic and placental drug metabolism in rats.

B. Hammock, W. Helferich, D. Moody, 1986, Biochemical pharmacology.

NADPH-dependent and -independent loss of cytochrome P-450 in control and phenobarbital-induced rat hepatic microsomes incubated with carbon tetrachloride.

E. Smuckler, C. Woo, D. Moody, 1986, Experimental and molecular pathology.

Disturbances in hepatic heme metabolism in rats administered alkyl halides.

E. Smuckler, D. Moody, David E. Moody, 1986, Toxicology letters.

Immunofluorescent determination of the lobular distribution of a constitutive form of hepatic microsomal cytochrome P‐450

E. Smuckler, D. Moody, L. Taylor, 1985, Hepatology.

Effects of 1,2-dibromo-3-chloropropane on hepatic heme synthesis.

G. Clawson, E. Smuckler, D. Moody, 1984, Toxicology and applied pharmacology.

Cytochrome P-450 lowering effect of alkyl halides, correlation with decrease in arachidonic acid.

E. Smuckler, D. Moody, J. James, 1980, Biochemical and biophysical research communications.

A validated liquid chromatography-atmospheric pressure chemical ionization-tandem mass spectrometry method for quantitation of cocaine and benzoylecgonine in human plasma.

G. Bigelow, R. Foltz, D. Moody, 2001, Journal of analytical toxicology.

Ketoconazole, a cytochrome P450 3A4 inhibitor, markedly increases concentrations of Levo‐acetyl‐α‐methadol in ppioid‐naive individuals

S. Walsh, D. Rollins, D. Moody, 2004, Clinical pharmacology and therapeutics.

Differential inhibition of indirect immunofluorescence in rat liver sections incubated with antibodies against microsomal cytochromes P-450a, b, and c and epoxide hydrolase.

E. Smuckler, D. Moody, L. Taylor, 1988, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

Peroxisome proliferators : unique inducers of drug-metabolizing enzymes

D. Moody, 1994 .

Epoxide metabolism in the liver of mice treated with clofibrate (ethyl-alpha-(p-chlorophenoxyisobutyrate)), a peroxisome proliferator.

B. Hammock, D. Loury, D. Moody, 1985, Toxicology and applied pharmacology.

Pharmacokinetics of Single-Dose Intramuscular and Subcutaneous Injections of Buprenorphine in Common Marmosets (Callithrix jacchus).

J. Fox, Monika A. Burns, D. Moody, 2021, Journal of the American Association for Laboratory Animal Science : JAALAS.

Detection of fentanyl and its analogs by enzyme-linked immunosorbent assay.

M. Y. Law, D. Rollins, D. Moody, 1990, Journal of analytical toxicology.

Effects of cannabinoids on preimplantation mouse embryo development and implantation are mediated by brain-type cannabinoid receptors.

S. Dey, A. Makriyannis, B. Paria, 1998, Biology of reproduction.

Azole antifungal inhibition of buprenorphine, methadone and oxycodone in vitro metabolism.

D. Moody, W. Fang, Fenyun Liu, 2015, Journal of analytical toxicology.

PHARMACOKINETICS AND DISPOSITION

D. Moody, Yan Chang, 2005 .

Safety of Intravenous Methamphetamine Administration During Ibudilast Treatment

S. Shoptaw, K. Heinzerling, D. Andrenyak, 2016, Journal of clinical psychopharmacology.

Interlobular distribution of hepatic xenobiotic-metabolizing enzyme activities in cattle, goats and sheep.

J. A. Wisniewski, B. Hammock, D. Moody, 1987, Journal of animal science.

Relative bioavailability of different buprenorphine formulations under chronic dosing conditions.

G. Bigelow, S. Walsh, E. Strain, 2004, Drug and alcohol dependence.

Purification of microsomal epoxide hydrolase from liver of rhesus monkey: partial separation of cis- and trans-stilbene oxide hydrolase.

B. Hammock, D. Moody, Bruce D. Hammock, 1987, Archives of biochemistry and biophysics.

In vitro inhibition of methadone and oxycodone cytochrome P450-dependent metabolism: reversible inhibition by H2-receptor agonists and proton-pump inhibitors.

D. Moody, W. Fang, Fenyun Liu, 2013, Journal of analytical toxicology.

Stereo-selective metabolism of methadone by human liver microsomes and cDNA-expressed cytochrome P450s: a reconciliation.

D. Moody, Yan Chang, W. Fang, 2011, Basic & clinical pharmacology & toxicology.

Inhibition of In Vitro Metabolism of Opioids by Skeletal Muscle Relaxants

D. Moody, W. Fang, Yueqiao Fu, 2018, Basic & clinical pharmacology & toxicology.

A liquid chromatographic-electrospray ionization-tandem mass spectrometric method for determination of buprenorphine, its metabolite, norbuprenorphine, and a coformulant, naloxone, that is suitable for in vivo and in vitro metabolism studies.

E. Strain, R. Foltz, M. Slawson, 2002, Analytical biochemistry.

Patterns of free (unconjugated) buprenorphine, norbuprenorphine, and their glucuronides in urine using liquid chromatography-tandem mass spectrometry.

G. McMillin, D. Moody, Heidi J Carlisle, 2012, Journal of analytical toxicology.

Effect of Rifampin and Nelfinavir on the Metabolism of Methadone and Buprenorphine in Primary Cultures of Human Hepatocytes

S. Strom, D. Moody, W. Fang, 2009, Drug Metabolism and Disposition.

Buprenorphine assay and plasma concentration monitoring in HIV-infected substance users.

M. Fischl, R. Reichman, B. Zingman, 2007, Journal of pharmaceutical and biomedical analysis.

Buprenorphine tablet versus liquid: a clinical trial comparing plasma levels, efficacy, and symptoms.

P. O'Connor, R. Schottenfeld, M. Chawarski, 2005, Journal of substance abuse treatment.

Simultaneous Determination of Ag-Tetrahydrocannabinol

John E. Newton, M. Huestis, R. Foltz, 2001 .

A radiometric TLC assay of liver microsomal dextromethorphan O-demethylation.

D. Moody, S. Singh, 1995, Journal of Pharmaceutical and Biomedical Analysis.

Urinary excretion of amphetamine and 4'-hydroxyamphetamine by Sprague Dawley and dark Agouti rats.

M. Y. Law, D. Moody, Micheal Y.L. Law, 1994, Life sciences.

Comparison of crude and affinity purified cytosolic epoxide hydrolases from hepatic tissue of control and clofibrate-fed mice.

G. Prestwich, B. Hammock, D. Loury, 1986, Archives of biochemistry and biophysics.

Comparative toxicology of tetrachlorobiphenyls in mink and rats. I. Changes in hepatic enzyme activity and smooth endoplasmic reticulum volume.

B. Hammock, W. Helferich, L. Lowenstine, 1987, Fundamental and applied toxicology : official journal of the Society of Toxicology.

Interactions between buprenorphine and antiretrovirals. II. The protease inhibitors nelfinavir, lopinavir/ritonavir, and ritonavir.

P. Jatlow, G. Friedland, Patrick F. Smith, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Determination of oxycodone, noroxycodone and oxymorphone by high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry in human matrices: in vivo and in vitro applications.

S. Walsh, M. Lofwall, D. Moody, 2013, Journal of analytical toxicology.

Effects of HCV seropositive status on buprenorphine pharmacokinetics in opioid-dependent individuals.

E. McCance-Katz, D. Moody, C. Masson, 2014, The American journal on addictions.

The integrity of liver protein synthesis in male rats treated with 1,2-dibromo-3-chloropropane.

G. Clawson, E. Smuckler, D. Moody, 1982, Toxicology letters.

Pertinence of nuclear envelope nucleoside triphosphatase activity to ribonucleic acid transport.

D. Friend, G. Clawson, E. Smuckler, 1980, Biochemistry.

Cellular distribution of cytochrome P-450 loss in rats of different ages treated with alkyl halides.

G. Clawson, E. Smuckler, C. Woo, 1982, Toxicology and applied pharmacology.

Immunohistochemical localization of cytochrome P-450a in liver sections from untreated rats and rats treated with phenobarbital or 3-methylcholanthrene.

P. Thomas, E. Smuckler, W. Levin, 1983, Drug metabolism and disposition: the biological fate of chemicals.

Simultaneous Determination of Δ9-Tetrahydrocannabinol and 11-nor-9-Carboxy-Δ9-Tetrahydrocannabinol in Human Plasma by Solid-Phase Extraction and Gas Chromatography-Negative Ion Chemical Ionization-Mass Spectrometry

M. Huestis, R. Foltz, D. Andrenyak, 2001 .

The effect of tetrahydrofuran on biological systems: does a hepatotoxic potential exist?

D. Moody, David E. Moody, 1991, Drug and chemical toxicology.

Determination of naltrexone and 6-beta-naltrexol in plasma by solid-phase extraction and gas chromatography-negative ion chemical ionization-mass spectrometry.

S. Walsh, R. Foltz, D. Moody, 1997, Journal of analytical toxicology.

The in vivo response of novel buprenorphine metabolites, M1 and M3, to antiretroviral inducers and inhibitors of buprenorphine metabolism.

E. McCance-Katz, D. Moody, Wei Huang, 2009, Basic & clinical pharmacology & toxicology.

Differential N-demethylation of l-alpha-acetylmethadol (LAAM) and norLAAM by cytochrome P450s 2B6, 2C18, and 3A4.

D. Moody, J. Neff, J. A. Neff, 2001, Biochemical and biophysical research communications.

A high-performance liquid chromatographic-atmospheric pressure chemical ionization-tandem mass spectrometric method for determination of risperidone and 9-hydroxyrisperidone in human plasma.

R. Foltz, D. Moody, Wei Huang, 2004, Journal of analytical toxicology.

Lack of clinically significant drug interactions between nevirapine and buprenorphine.

E. McCance-Katz, G. Morse, D. Moody, 2010, The American journal on addictions.

Metabolism of capsaicin by cytochrome P450 produces novel dehydrogenated metabolites and decreases cytotoxicity to lung and liver cells.

A. Mutlib, P. Kulanthaivel, C. Reilly, 2003, Chemical research in toxicology.

Pharmacokinetics of 2 formulations of buprenorphine in macaques (Macaca mulatta and Macaca fascicularis).

D. Moody, L. Halliday, W. Fang, 2013, Journal of the American Association for Laboratory Animal Science : JAALAS.

Peroxisome-associated enzymes and serum lipids in tumour-bearing rats treated with peroxisome-proliferating agents.

D. Azarnoff, D. Moody, J. Reddy, 1984, Biochemical pharmacology.

Nuclear envelope alterations accompanying thioacetamide-related enlargement of the nucleus.

G. Clawson, E. Smuckler, D. Moody, 1981, Cancer research.

A methodology for the analysis of the preneoplastic antigen.

P. Volberding, R. Baselt, K. Milam, 1984, Carcinogenesis.

Serum epoxide hydrolase (preneoplastic antigen) in human and experimental liver injury.

J. Cullen, B. Ruebner, B. Hammock, 1992, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Hepatic peroxisome (microbody) proliferation in rats fed plasticizers and related compounds.

J K Reddy, D. Moody, D E Moody, 1978, Toxicology and applied pharmacology.

Effect of dietary clofibrate on epoxide hydrolase activity in tissues of mice.

B. Hammock, D. Loury, D. Moody, 1985, Biochemical pharmacology.

Could Postnatal Age–Related Uridine Diphosphate Glucuronic Acid Be a Rate‐Limiting Factor in the Metabolism of Morphine During the First Week of Life?

V. Ivaturi, Tao Liu, J. Gobburu, 2019, CPT: pharmacometrics & systems pharmacology.

Interaction between buprenorphine and atazanavir or atazanavir/ritonavir.

G. Friedland, P. Pade, E. McCance-Katz, 2007, Drug and alcohol dependence.

Pharmacokinetic Interactions Between Buprenorphine/Naloxone and Once-Daily Lopinavir/Ritonavir

R. D. Bruce, F. Altice, G. Friedland, 2010, Journal of acquired immune deficiency syndromes.

A review of pharmacological interactions between HIV or hepatitis C virus medications and opioid agonist therapy: implications and management for clinical practice

R. D. Bruce, F. Altice, G. Friedland, 2013, Expert review of clinical pharmacology.

Interactions between buprenorphine and the protease inhibitors darunavir-ritonavir and fosamprenavir-ritonavir.

Gene D Morse, Petrie M Rainey, V. Gruber, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Drug Interactions with Benzodiazepines: Epidemiologic Correlates with Other CNS Depressants and In Vitro Correlates with Inhibitors and Inducers of Cytochrome P450 3A4

D. Moody, 2012 .

Formulation of buprenorphine for sublingual use in neonates.

W. Kraft, K. Dysart, D. Moody, 2011, The Journal of Pediatric Pharmacology and Therapeutics.

Stability of plasma gamma-hydroxybutyrate determined by gas chromatography-positive ion chemical ionization-mass spectrometry.

R. Foltz, D. Andrenyak, D. Moody, 2003, Journal of analytical toxicology.

Long-term stability of abused drugs and antiabuse chemotherapeutical agents stored at -20°C

D. Moody, A. C. Spanbauer, J. Hsu, 1999 .

Enantioselective gas chromatography-negative ion chemical ionization mass spectrometry for methylphenidate in human plasma.

R. Foltz, D. Andrenyak, D. Moody, 1999, Journal of analytical toxicology.

Determination of methadone and its N-demethylation metabolites in biological specimens by GC-PICI-MS.

R. Foltz, D. Moody, M. Alburges, 1996, Journal of analytical toxicology.

Long-Term Stability of Abused Drugs and Antiabuse Chemotherapeutical Agents Stored at-20 ~

D. Moody, A. C. Spanbauer, K. Monti, 2008 .

Opioid plasma concentrations in methadone‐and buprenorphine‐maintained patients

R. Jagsch, D. Moody, G. Fischer, 2005, Addiction biology.

The involvement of cytochrome P450 3A4 in the N-demethylation of L-alpha-acetylmethadol (LAAM), norLAAM, and methadone.

J. Strong, R. Parker, D. Moody, 1997, Drug metabolism and disposition: the biological fate of chemicals.

The documented role of pharmacogenetic: in the identification and administration of new medications for treating drug abuse.

R. Tyndale, E. Sellers, R. Woosley, 1996, NIDA research monograph.

A gas chromatographic-positive ion chemical ionization-mass spectrometric method for determination of cocaine, benzoylecgonine, ecgonine methyl ester, and norcocaine in plasma: detection of norcocaine in plasma after oral administration of cocaine.

S. Walsh, R. Foltz, D. Moody, 2000, Journal of analytical toxicology.

Determination of buprenorphine in human plasma by gas chromatography-positive ion chemical ionization mass spectrometry and liquid chromatography-tandem mass spectrometry.

D J Crouch, R L Foltz, W K Bickel, 1997, Journal of analytical toxicology.

Determination of ibogaine and 12-hydroxy-ibogamine in plasma by gas chromatography-positive ion chemical ionization-mass spectrometry.

R. Foltz, D. Moody, M. Alburges, 1995, Journal of analytical toxicology.

A gas chromatographic-positive ion chemical ionization-mass spectrometric method for the determination of I-alpha-acetylmethadol (LAAM), norLAAM, and dinorLAAM in plasma, urine, and tissue.

D. Crouch, R. Foltz, D. Moody, 1995, Journal of analytical toxicology.

Sublingual Buprenorphine for Treatment of Neonatal Abstinence Syndrome: A Randomized Trial

M. Ehrlich, W. Kraft, J. Greenspan, 2008, Pediatrics.

Analysis for Alpha-Pyrrolidinovalerophenone and its 2-oxo-PVP Metabolite in Plasma by LiquidChromatography-Tandem Mass Spectrometry.

D. Andrenyak, D. Moody, M. Baumann, 2019, Journal of analytical toxicology.

Peroxisome proliferation and nongenotoxic carcinogenesis: Commentary on a symposium

B. Lake, J. Popp, D. Reese, 1991 .

Simultaneous determination of delta9-tetrahydrocannabinol and 11-nor-9-carboxy-delta9-tetrahydrocannabinol in human plasma by solid-phase extraction and gas chromatography-negative ion chemical ionization-mass spectrometry.

M. Huestis, R. Foltz, D. Andrenyak, 2001, Journal of analytical toxicology.

Absence of increased carnitine acetyltransferase activity in the liver with proliferation of smooth endoplasmic reticulum.

D. Moody, J. Reddy, 1977, Biochemical pharmacology.

Immunoassay detection of benzodiazepines and benzodiazepine metabolites in blood.

D. Moody, W. Huang, W. Huang, 1995, Journal of analytical toxicology.

Urinary excretion of 4-hydroxyamphetamine and amphetamine in male and female Sprague-Dawley and Dark Agouti rats following multiple doses of amphetamine.

M. Y. Law, D. Moody, 2000, Toxicology letters.

Determination of naloxone and nornaloxone (noroxymorphone) by high-performance liquid chromatography-electrospray ionization- tandem mass spectrometry.

E. McCance-Katz, D. Moody, Yan Chang, 2009, Journal of analytical toxicology.

Selective involvement of cytochrome P450 2D subfamily in in vivo 4-hydroxylation of amphetamine in rat.

M. Y. Law, M. Slawson, D. Moody, 2000, Drug metabolism and disposition: the biological fate of chemicals.

Simultaneous Quantitation of Amphetamine and 4′-Hydroxyamphetamine by High Performance Liquid Chromatography

M. Y. Law, D. Moody, 1995 .

Quinidine inhibits in vivo metabolism of amphetamine in rats: impact upon correlation between GC/MS and immunoassay findings in rat urine.

M. Y. Law, D. Moody, W. Ruangyuttikarn, 1990, Journal of analytical toxicology.

Comparison of three commercial amphetamine immunoassays for detection of methamphetamine, methylenedioxyamphetamine, methylenedioxymethamphetamine, and methylenedioxyethylamphetamine.

D. Moody, W. Ruangyuttikarn, 1988, Journal of analytical toxicology.

Zhx2 Is a Candidate Gene Underlying Oxymorphone Metabolite Brain Concentration Associated with State-Dependent Oxycodone Reward

Martin T. Ferris, A. Emili, G. Peltz, 2022, The Journal of Pharmacology and Experimental Therapeutics.

Concomitant induction of microsomal epoxide hydrolase and UDP-glucuronosyltransferase activities by dipyridine compounds.

D. Moody, M. Franklin, 1992, Drug Metabolism And Disposition.

Application of programmable bio-nano-chip system for the quantitative detection of drugs of abuse in oral fluids.

John T McDevitt, Michael P McRae, Jorge Wong, 2015, Drug and alcohol dependence.

Repeated dosing with oral cocaine in humans: assessment of direct effects, withdrawal, and pharmacokinetics.

G. Bigelow, S. Walsh, W. Stoops, 2009, Experimental and clinical psychopharmacology.

Effect of cocaine use on buprenorphine pharmacokinetics in humans.

E. McCance-Katz, D. Moody, P. Rainey, 2010, The American journal on addictions.

Effects of Buprenorphine Maintenance Dose on μ-Opioid Receptor Availability, Plasma Concentrations, and Antagonist Blockade in Heroin-Dependent Volunteers

Robert A Koeppe, Michael R Kilbourn, Mark K Greenwald, 2003, Neuropsychopharmacology.

Effects of thioacetamide treatment on nuclear envelope nucleoside triphosphatase activity and transport of RNA from rat liver nuclei.

G. Clawson, E. Smuckler, D. Moody, 1980, Cancer research.

Cyclopropyl oxiranes: reversible inhibitors of cytosolic and microsomal epoxide hydrolases.

G. Prestwich, B. Hammock, D. Loury, 1985, Archives of biochemistry and biophysics.

Developmental Toxicity of Levo-Alpha-Acetylmethadol (LAAM) in Tolerant Rats

R. G. York, D. Moody, M. Alburges, 2002, International journal of toxicology.

Cocaine cardiovascular effects and pharmacokinetics after treatment with the acetylcholinesterase inhibitor donepezil.

K. Grasing, T. Newton, D. Moody, 2016, The American journal on addictions.

The pharmacodynamic and pharmacokinetic profile of intranasal crushed buprenorphine and buprenorphine/naloxone tablets in opioid abusers.

S. Walsh, M. Lofwall, P. Nuzzo, 2011, Addiction.

Gas chromatography/mass spectrometry assays for the determination of debrisoquine and sparteine metabolites in microsomal fractions of rat liver.

D. Moody, J. Ho, 1992, Analytical biochemistry.

Determination of tolbutamide hydroxylation in rat liver microsomes by high-performance liquid chromatography: effect of psychoactive drugs on in vitro activity.

D. Moody, J. Ho, 1993, Life sciences.

An injection depot formulation of buprenorphine: extended bio-delivery and effects.

G. Bigelow, D. Moody, S. Sigmon, 2006, Addiction.

A comparative evaluation of the instant-view 5-panel test card with OnTrak TesTcup Pro 5: comparison with gas chromatography-mass spectrometry.

D. Andrenyak, D. Moody, Wenfang B Fang, 2006, Journal of analytical toxicology.

Analysis of cocaine and its metabolites from biological specimens using solid-phase extraction and positive ion chemical ionization mass spectrometry.

D. Crouch, D. Rollins, D. Moody, 1995, Journal of analytical toxicology.

Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxone.

R. D. Bruce, F. Altice, G. Friedland, 2009, Drug and alcohol dependence.

Characterization of a bovine gene encoding an ankyrin repeat and SOCS box protein (ASB15).

T. McDaneld, D. Moody, 2003, Animal Genetics.

Medical Toxicology of Drug Abuse: Synthesized Chemicals and Psychoactive Plants

D. Moody, 2013 .

Comparison of immunoassays for semiquantitative measurement of benzoylecgonine in urine.

S. Reuschel, R. Foltz, D. Moody, 1997, NIDA research monograph.

Pharmacokinetics, bioavailability and opioid effects of liquid versus tablet buprenorphine.

W. Ling, P. Compton, D. Moody, 2006, Drug and alcohol dependence.

Immunoassay detection of nordiazepam, triazolam, lorazepam, and alprazolam in blood.

D. Andrenyak, D. Rollins, D. Moody, 1993, Journal of analytical toxicology.

The Pharmacokinetics and Pharmacodynamics of Buprenorphine in Neonatal Abstinence Syndrome

M. Ehrlich, W. Kraft, M. Gastonguay, 2018, Clinical pharmacology and therapeutics.

Gender differences in pharmacokinetics of maintenance dosed buprenorphine.

E. McCance-Katz, D. Moody, W. Fang, 2011, Drug and alcohol dependence.

The effect of structurally divergent herbicides on mouse liver xenobiotic-metabolizing enzymes (P-450-dependent mono-oxygenases, epoxide hydrolases and glutathione S-transferases) and carnitine acetyltransferase.

B. Hammock, D. Moody, L. Shull, 1991, Toxicology letters.

Quantitative analysis of selegiline and three metabolites (N-desmethylselegiline, methamphetamine, and amphetamine) in human plasma by high-performance liquid chromatography-atmospheric pressure chemical ionization-tandem mass spectrometry.

R. Foltz, M. Slawson, D. Moody, 2002, Journal of analytical toxicology.

Population Pharmacokinetic Model of Sublingual Buprenorphine in Neonatal Abstinence Syndrome

J. Barrett, W. Kraft, D. Moody, 2015, Pharmacotherapy.

Epoxide hydrolases in the catabolism of sterols and isoprenoids.

B. Hammock, A. Sevanian, D. Moody, 1985, Methods in enzymology.

Peroxisome proliferators, a unique set of drug-metabolizing enzyme inducers: commentary on a symposium.

J. Magdalou, D. Grant, G. Gibson, 1992, Drug metabolism and disposition: the biological fate of chemicals.

EPOXIDE HYDROLYSIS IN THE CYTOSOL OF RAT LIVER , KIDNEY , A N D TESTIS

B. Hammock, Marilyn H Silva, D. Moody, 2002 .

Apparent differential response of nuclear envelope cytochrome P-450 following phenobarbital induction arising from a preferential loss during gradient purification.

G. Clawson, E. Smuckler, C. Woo, 1981, Cancer research.

Phenobarbital pretreatment alters the localization of CCl4-induced changes in rat liver microsomal fatty acids.

E. Smuckler, D. Moody, J. James, 1990, Toxicology and applied pharmacology.

The phospholipids of the hepatic endoplasmic reticulum. Structural change in liver injury.

E. Smuckler, D. Moody, C. Chan, 1982, The Biochemical journal.

Correlations among the changes in hepatic microsomal components after intoxication with alkyl halides and other hepatotoxins.

G. Clawson, E. Smuckler, D. Moody, 1981, Molecular pharmacology.

Reduction in hepatic microsomal cytochromes P-450 and b5 in rats exposed to 1,2-dibromo-3-chloropropane and carbon tetrachloride: enhancement of effect by pretreatment with phenobarbital.

E. Smuckler, D. Moody, B. Head, 1979, Journal of Environmental Pathology And Toxicology.

Peroxisome proliferation and nongenotoxic carcinogenesis: commentary on a symposium.

B. Lake, J. Popp, D. Reese, 1991, Fundamental and applied toxicology : official journal of the Society of Toxicology.

Pharmacokinetics, blood and urine profile effects, and injection site histopathology following three daily injections of subcutaneous high concentration buprenorphine in New Zealand white rabbits (Oryctolagus cuniculus)

J. Ritchey, M. Breshears, P. Rudra, 2022, Journal of Exotic Pet Medicine.

Pharmacokinetics of Buprenorphine and Sustained-release Buprenorphine in Common Marmosets (Callithrix jacchus).

D. Moody, W. Fang, Anna E Goodroe, 2020, Journal of the American Association for Laboratory Animal Science : JAALAS.

A liquid chromatography-electrospray ionization-tandem mass spectrometry method for quantitation of aripiprazole in human plasma.

M. Reid, T. Newton, R. Foltz, 2009, Journal of analytical toxicology.

Evaluation of immunoassays for semiquantitative detection of cocaine and metabolites or heroin and metabolites in extracts of sweat patches.

D. Moody, M. Cheever, 2001, Journal of analytical toxicology.

Increased nucleoside triphosphatase activity of rat liver nuclear envelope is associated with hepatocarcinogen exposure.

L. Ferrell, G. Clawson, E. Smuckler, 1984, Laboratory investigation; a journal of technical methods and pathology.

Determination of riboflavin by high-performance liquid chromatography with riboflavin-depleted urine as calibration and control matrix.

R. Foltz, D. Andrenyak, D. Moody, 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

The inhibition of first-pass metabolism of ethanol by H2-receptor antagonists: a tabulated review

D. Moody, 2018, Expert opinion on drug safety.

Comparative analysis of sweat patches for cocaine (and metabolites) by radioimmunoassay and gas chromatography-positive ion chemical ionization-mass spectrometry.

D. Moody, A. C. Spanbauer, James L Taccogno, 2004, Journal of analytical toxicology.

Analysis of Forensic Specimens for Cannabinoids. II. Relationship Between Blood Δ9-Tetrahydrocannabinol and Blood and Urine 11-nor-Δ9-Tetrahydrocannabinol-9-carboxylic Acid Concentrations

D. Crouch, D. Moody, K. Monti, 1992 .

Pharmacokinetics of Intranasal Crushed OxyContin and Intravenous Oxycodone in Nondependent Prescription Opioid Abusers

S. Walsh, D. Moody, David E. Moody, 2012, Journal of clinical pharmacology.

Glucuronidation of buprenorphine and norbuprenorphine by human liver microsomes and UDP-glucuronosyltransferases.

D. Moody, Yan Chang, 2009, Drug metabolism letters.

Effect of benzodiazepines on the metabolism of buprenorphine in human liver microsomes

D. Moody, Yan Chang, 2005, European Journal of Clinical Pharmacology.

The impact of recent cocaine use on plasma levels of methadone and buprenorphine in patients with and without HIV-infection.

L. Fiellin, D. Fiellin, E. McCance-Katz, 2015, Journal of substance abuse treatment.

Detection and time course of cocaine N-oxide and other cocaine metabolites in human plasma by liquid chromatography/tandem mass spectrometry.

S. Walsh, R. Foltz, D. Moody, 2003, Analytical chemistry.

Fate of Systemically Administered Cocaine in Nonhuman Primates Treated with the dAd5GNE Anti-cocaine Vaccine.

G. Koob, R. Crystal, S. Evans, 2014, Human gene therapy. Clinical development.

A Possible Mechanistic Link Between the CYP2C19 Genotype, the Methadone Metabolite Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidene (EDDP), and Methadone-Induced Corrected QT Interval Prolongation in a Pilot Study

J. Carlquist, L. Webster, John A. Huntinghouse, 2015, Molecular Diagnosis & Therapy.

pharmacologically and surgically induced hypertrophy Myogenin, MyoD, and myosin expression after

Sunil K. Kakarla, David J. Kosek, J. Petrella, 2015 .

Fate of systemically administered cocaine in nonhuman primates treated with the dAd5GNE anticocaine vaccine.

G. Koob, R. Crystal, S. Evans, 2014, Human gene therapy. Clinical development.

Varenicline treatment for methamphetamine dependence: A randomized, double-blind phase II clinical trial.

S. Shoptaw, R. Cook, A. Swanson, 2018, Drug and alcohol dependence.

Identification of quantitative trait loci associated with egg quality, egg production, and body weight in an F2 resource population of chickens.

P. Settar, M. Schreiweis, P. Hester, 2006, Animal genetics.

Formulation of buprenorphine for sublingual use in neonates.

W. Kraft, D. Moody, Ellena A Anagnostis, 2011, The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG.